Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models - PubMed (original) (raw)
Affiliations
- PMID: 2598414
Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models
G F Evans et al. Circ Shock. 1989 Dec.
Abstract
Murine shock models have employed bolus endotoxin as well as cecal ligation and puncture (CLP) in an attempt to understand the pathophysiologic changes associated with human septic shock. Injection of endotoxin results in a rapid but transient rise in tumor necrosis factor (TNF), with maximal levels between 1 and 2 hr followed by an increase in serum interleukin-1 (IL-1) by 3 hr which remains elevated at 24 hr. CLP animals in contrast do not demonstrate an elevation in serum TNF, and the increase in IL-1 is less significant relative to the endotoxin model. Whereas both models demonstrate comparable increases in serum amyloid A protein and result in host death between 24 and 48 hr, these models respond differently to therapeutic modalities. Steroids and an anti-TNF monoclonal antibody administered prophylactically are effective at preventing death in the endotoxin model and yet had no beneficial effect in antibiotic-treated CLP animals. Experiments with adrenalectomized mice suggest that the absence of serum TNF in the CLP model is in part due to the modulatory effects of endogenous corticosteroids.
Similar articles
- Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Eskandari MK, et al. J Immunol. 1992 May 1;148(9):2724-30. J Immunol. 1992. PMID: 1315357 - In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.
Zuckerman SH, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. Zuckerman SH, et al. Immunology. 1995 Sep;86(1):18-24. Immunology. 1995. PMID: 7590877 Free PMC article. - Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin.
Hadjiminas DJ, McMasters KM, Peyton JC, Cheadle WG. Hadjiminas DJ, et al. J Surg Res. 1994 Jun;56(6):549-55. doi: 10.1006/jsre.1994.1088. J Surg Res. 1994. PMID: 8015310 - The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.
Dinarello CA. Dinarello CA. J Infect Dis. 1991 Jun;163(6):1177-84. doi: 10.1093/infdis/163.6.1177. J Infect Dis. 1991. PMID: 2037782 Review. - Invited comment: monokine metabolism in the septic syndrome.
Long CL. Long CL. JPEN J Parenter Enteral Nutr. 1988 Nov-Dec;12(6 Suppl):78S-81S. doi: 10.1177/014860718801200609. JPEN J Parenter Enteral Nutr. 1988. PMID: 3063843 Review. No abstract available.
Cited by
- Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.
Alexander HR, Sheppard BC, Jensen JC, Langstein HN, Buresh CM, Venzon D, Walker EC, Fraker DL, Stovroff MC, Norton JA. Alexander HR, et al. J Clin Invest. 1991 Jul;88(1):34-9. doi: 10.1172/JCI115298. J Clin Invest. 1991. PMID: 2056127 Free PMC article. - Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.
Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Pagani FD, et al. J Clin Invest. 1992 Aug;90(2):389-98. doi: 10.1172/JCI115873. J Clin Invest. 1992. PMID: 1644912 Free PMC article. - Molecular and cellular aspects of sepsis-induced immunosuppression.
Wang TS, Deng JC. Wang TS, et al. J Mol Med (Berl). 2008 May;86(5):495-506. doi: 10.1007/s00109-007-0300-4. Epub 2008 Feb 8. J Mol Med (Berl). 2008. PMID: 18259721 Review. - Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice.
Hyde SR, McCallum RE. Hyde SR, et al. Infect Immun. 1992 Mar;60(3):976-82. doi: 10.1128/iai.60.3.976-982.1992. Infect Immun. 1992. PMID: 1541572 Free PMC article. - The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.
Reckless J, Tatalick LM, Grainger DJ. Reckless J, et al. Immunology. 2001 Jun;103(2):244-54. doi: 10.1046/j.1365-2567.2001.01228.x. Immunology. 2001. PMID: 11412312 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous